IMI at BIO 2017

Start Date 19/06/2017 End Date 22/06/2017
San Diego, USA

IMI took part in this year’s BIO International Convention which was held in San Diego, US on 19 to 22 June 2017.

On Thursday 22 June, IMI organised a session (ID 22035) in the digital health track of the BIO educational programme:

‘Detect, Predict, Prevent: Using Digital Technologies to Tackle Brain Disorders

Imagine being able to use a smartphone and a wearable device that detect changes in your behaviour, sleep, movement and social interaction. For people affected by brain disorders, such as depression, multiple sclerosis and epilepsy, this information could help to predict, and maybe even prevent, a relapse. For those with dementia, it could allow users to track changes in their cognitive abilities and make it easier for them to communicate with care givers and loved ones. For researchers, the data gathered could aid in the identification of endpoints for clinical studies.

This session attracted over 100 participants and looked to answer such pressing questions as: How can we ensure the quality of the data generated? How can researchers, regulators and patients keep pace with rapid developments in technology? And most importantly, how can we best capture those breakthroughs that have the potential to improve patients’ lives?

Among other things, the session highlighted the work of IMI's RADAR-CNS project.



  • Chuck McClatchey | National Early-Stage Advisor, Alzheimer’s Association
  • David Mohr | Director, Center for Behavioral Intervention Technologies, Professor of Preventive Medicine, Northwestern University Feinberg School of Medicine - presentation
  • Nelson Freimer | Director of the Depression Grand Challenge (DGC) at the University of California, Los Angeles (UCLA)
  • Husseini K. Manji | Global Therapeutic Head, Neuroscience, Janssen Research & Development

IMI at the exhibition

IMI was also present at the European Commission’s booth at the BIO Exhibition
Download a brochure about the EU pavilion

About BIO

The 2017 BIO International Convention (BIO) attracted 16 100 attendees from 74 countries, including biotechnology and pharma leaders who came together for a week of intensive networking and partnering opportunities. The event featured a strong educational programme with over 145 sessions, as well as an expansive exhibition floor counting 1 800 exhibitors.